Adenocarcinoma of the Pancreas Withdrawn Phase 2 Trials for Gemcitabine (DB00441)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00253526Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic CancerTreatment
NCT02850874HIPEC as Neoadjuvant Treatment for Resectable Pancreatic AdenocarcinomaTreatment
NCT00728000Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic AdenocarcinomaTreatment